Follicular Lymphoma Drugs market was valued at USD 2.02 billion in 2025
According to a new report from Intel Market Research, the global Follicular Lymphoma Drugs market was valued at USD 2.02 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 8.7% during the forecast period (2026–2034). This growth is propelled by the rising prevalence of low‑grade non‑Hodgkin lymphoma among an ageing population, accelerating...
0 Commentaires 0 Parts 3 Vue 0 Aperçu
BuzzingAbout https://www.buzzingabout.com